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Abstract
Background: The quality of microarray data can seriously affect the accuracy of downstream
analyses. In order to reduce variability and enhance signal reproducibility in these data, many
normalization methods have been proposed and evaluated, most of which are for data obtained
from cDNA microarrays and Affymetrix GeneChips. CodeLink Bioarrays are a newly emerged,
single-color oligonucleotide microarray platform. To date, there are no reported studies that
evaluate normalization methods for CodeLink Bioarrays.
Results: We compared five existing normalization approaches, in terms of both noise reduction
and signal retention: Median (suggested by the manufacturer), CyclicLoess, Quantile, Iset, and
Qspline. These methods were applied to two real datasets (a time course dataset and a lung
disease-related dataset) generated by CodeLink Bioarrays and were assessed using multiple
statistical significance tests. Compared to Median, CyclicLoess and Qspline exhibit a significant and
the most consistent improvement in reduction of variability and retention of signal. CyclicLoess
appears to retain more signal than Qspline. Quantile reduces more variability than Median in both
datasets, yet fails to consistently retain more signal in the time course dataset. Iset does not
improve over Median in either noise reduction or signal enhancement in the time course dataset.
Conclusion: Median is insufficient either to reduce variability or to retain signal effectively for
CodeLink Bioarray data. CyclicLoess is a more suitable approach for normalizing these data.
CyclicLoess also seems to be the most effective method among the five different normalization
strategies examined.
Background
DNA microarrays have made possible the expression pro-
filing of thousands of genes in a single experiment. They
have been used in a wide range of applications, e.g., dis-
ease classification and characterization [1-4], discovery of
new disease subtypes [5,6], and identification of novel
genes or gene regulatory networks for biological mecha-
nistic research [7,8]. Depending on the probe types used,
DNA microarrays can be classified as either cDNA or oli-
gonucleotide microarrays. Additionally, depending on the
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number of samples hybridized to a single array, microar-
rays can be classified as single-color or two-color arrays.
CodeLink Bioarrays are recently developed, single-color
oligonucleotide microarrays, which differ from Affymetrix
GeneChips (the largest and most established microarray
manufacturer) mainly in that, in order to detect a target
transcript, CodeLink Bioarrays use a single 30-mer oligo-
nucleotide probe, whereas GeneChips use multiple 25-
mer probes. CodeLink Bioarrays have been applied suc-
cessfully to identify and characterize target genes involved
in idiopathic pulmonary fibrosis [9] and emphysema
[10], to identify molecular signatures in colon cancer
development [11] and postnatal uterine development
[12], and to elucidate transcriptional mechanisms under-
lying the osteogenic process [13].
Regardless of platforms, microarray data are noisy due to
the co-existence of genuine biological variations (signal)
and noise. Signal is desirable and makes samples of differ-
ent biological natures distinguishable from one another.
Noise, however, is of no biological relevance and can arise
from any step: sample preparation, labelling, hybridiza-
tion, or scanning [14]. Moreover, noise can hide meaning-
ful biological signal and seriously skew the results of
downstream data analyses. Therefore, it must be mini-
mized to ensure the accuracy of downstream studies. In
order to do so, many normalization strategies have been
proposed and evaluated, but most have been for data
obtained from cDNA microarrays [15,16] and from
Affymetrix GeneChips [17,18]. Since both CodeLink Bio-
arrays and GeneChips are single-color oligonucleotide
microarrays, data generated from these platforms can usu-
ally be normalized by the same approaches. However,
because of differences in array designs, methods that per-
form well for one platform may not work equally well for
the other. It is, therefore, still necessary to validate nor-
malization methods for CodeLink Bioarrays. To date,
there have been no reported studies that evaluated nor-
malization methods for CodeLink arrays.
A challenge inherent for the normalization of microarray
data is the lack of a gold standard (e.g., a 'perfect' valida-
tion set that can reflect the complexity of real data). It is,
therefore, not easy to identify the best normalization
method(s) (which can both remove noise and retain sig-
nal most effectively) for any array platform. Two criteria
have been employed to compare normalization strategies
[17-19]: one is the ability to reduce noise in the data and
the other is the ability to retain biological signal. To assess
noise reduction, diagnostic plots have been employed to
visualize and identify noise in the data. For example, the
MA plot, which is the scatter plot of average log intensity
values (A) of the green and red fluorescent dyes (in two-
color cDNA microarrays) vs. log intensity ratio (M) of the
two fluorescent dyes, has been used to identify intensity-
dependent dye effect in cDNA microarray data [19]; while
the spatial plot, a spatial representation of the spots on a
microarray color-coded by their intensity values, has been
used to evaluate spatial-dependent dye effect in cDNA
microarray data [20]. Other approaches have used the
coefficient of variation [21,22], correlation [21] and vari-
ance [23] in replicate arrays, as quantitative, unambigu-
ous measures to evaluate the effectiveness of
normalization methods in removing variability.
It is relatively ambiguous to evaluate normalization meth-
ods in terms of signal retention, because there is no
ground truth for total signal in real biological samples.
Prevailing approaches compare the ability to predict a
fixed number of known differentially expressed genes
using t-statistics [19] and adjusted p-values [24] and to
reveal spike-in genes [17]. When little is known about dif-
ferentially expressed genes in the data (a common situa-
tion when real datasets are used), signal has been
estimated by calculating the overabundance of differen-
tially expressed genes or informative genes from real data-
sets [18]. The leave-one-out cross-validation k-NN
classification error has also been employed as a functional
measure for comparing normalization methods in real
datasets [16].
Previously we have developed a strategy for the evaluation
of normalization approaches for Affymetrix GeneChips
[18]. In the present study, we employed a similar strategy
to compare five existing normalization methods (Median,
CyclicLoess, Quantile, Iset, and Qspline) for CodeLink
Bioarray data. These methods were designed for high-den-
sity oligonucleotide microarrays, and some of them
(Median, CyclicLoess, Quantile, and Iset) have already
been validated using GeneChip data [17,18]. We applied
these normalization approaches individually to two real
datasets obtained from CodeLink Bioarrays. We examined
intensity-dependent differences in the normalized data-
sets and assessed variability of the normalized datasets,
using replicate microarrays and/or positive control probes
on the arrays. Finally, to assess the effectiveness of the nor-
malization methods in retaining signal, we compared the
numbers of differentially expressed genes detected from
the normalized datasets using multiple statistical signifi-
cance tests. Computer programs in this work were imple-
mented using the R language for statistical computing and
graphics [25].
Results
Noise in the normalized time course dataset
Intensity-dependent differences in the normalized data
We used pairwise MA plots to examine the ability of the
normalization methods to remove intensity-dependent
differences between each pair of arrays in the technical
replicates. Figure 1 shows the MA plots of two pairs ofBMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
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arrays in the TRC1 replicate data, either non-normalized
(Nonorm), or normalized with the five normalization
methods. These arrays exhibit obvious intensity-depend-
ent differences between "pair 1" (array 1 vs. array 4) and
"pair 2" (array 4 vs. array 5) (shown as curved loess lines
in the plots) (Figure 1, Nonorm). For the Median-normal-
ized data, although the loess lines are centered near zero,
they still have curvature, indicating that Median does not
remove intensity-dependent differences adequately (Fig-
ure 1, Median). CyclicLoess, Quantile and Qspline
remove intensity-dependent differences almost com-
pletely; Iset, however, fails to remove all the intensity-
dependent differences (Figure 1).
Variability of the normalized data
We calculated the coefficient of variation (CV) of the nor-
malized intensity values for each transcript across all
arrays in each set of the normalized technical replicates.
Figure 2 shows the density plots of the CVs for Nonorm
and the five normalization methods. The CV of Nonorm
in TRC1 peaks more to the left side with a wider spread
than those in TRC2 and TRC3, suggesting that the quality
of the TRC1 replicates is not as good as those of TRC2 and
TRC3. This is consistent with our observation that TRC1
contains two 'corrupted' pairs of arrays that show obvious
intensity-dependent differences in the MA plots (Figure
1). Figure 2 shows that in TRC1, the five normalization
methods reduce the data variability to different degrees:
Iset and CyclicLoess have overall lower CVs (and thus per-
form better) than Median, Quantile and Qspline, as indi-
cated by the CV density plots of the former methods peak
more to the left side of those of the latter approaches;
Quantile and Qspline have slightly lower CVs than
Median. In TRC2 (Figure 2), Iset fails to improve over
Median, whereas the performances of the other four nor-
malization methods (CyclicLoess, Quantile, Qspline, and
Median) are similar. In TRC3, Median is outperformed by
all the other four normalization strategies (Figure 2).
Finally, we calculated the CVs of the normalized intensity
values for positive control probes across all arrays in the
time course dataset. Our results show that CyclicLoess,
Quantile and Qspline reduce variability from the normal-
ized data more effectively than Nonorm, Median and Iset.
The means of the CVs for CyclicLoess, Quantile and
Qspline are 57%, 54% and 56% respectively, whereas the
means of the CVs for Nonorm, Median and Iset are 72%,
66% and 61% respectively. CyclicLoess has a slightly
higher mean CV than Quantile and Qspline, but the dif-
ferences are not statistically significant (Welch's t-tests, p-
values > 0.05).
These results suggest that overall CyclicLoess reduces vari-
ability most effectively and consistently than Median in
both the 'corrupted' (TRC1) and good-quality (TRC2 and
MA plots of two pairs of microarrays in the TRC1 replicate  set from the time course dataset Figure 1
MA plots of two pairs of microarrays in the TRC1 
replicate set from the time course dataset. The plots 
in each row show the results from non-normalized data (row 
1) and data normalized with each of the five normalization 
methods (row 2–6). Columns depict two pairs of microar-
rays, pair 1 (array 1 vs. array 4, left) and pair 2 (array 4 vs. 
array 5, right), in the TRC1 replicates that exhibit obvious 
intensity-dependent differences between the arrays. The yel-
low line in each plot shows the loess fitting of the entire data 
in the plot.
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TRC3) data. Although Quantile and Qspline perform as
well as CyclicLoess in the good-quality data, CyclicLoess
outperforms them in the 'corrupted' data. Iset fails to
improve over Median consistently.
Signal in the normalized time course dataset
Since the aim of an effective normalization method is to
remove noise while retaining biological signal in the data,
we next compared the effectiveness of the normalization
approaches in signal retention. As no spike-in datasets
were available for CodeLink Bioarrays, we were unable to
determine total signal in the data. Instead, we estimated
signal by calculating the number of differentially
expressed genes in the data. We expected that the more
signal retained, the more differentially expressed genes
should be revealed. Although similar methodology has
been shown effective in our previous work [18], we devel-
oped a statistical model and used simulated data to illus-
trate the validity of this intuition (see additional file 1:
Simulation model and data for detail).
We then used Welch's two sample t-tests and Wilcoxon
rank sum tests, with and without permutation, to estimate
the numbers of differentially expressed genes in the non-
normalized data and in the data normalized with the five
normalization methods. For each statistical test, Figure 3
shows the numbers of differentially expressed genes esti-
mated from the normalized data at different time points.
We ranked all the normalization methods at each time
point based on the numbers of differentially expressed
genes detected (Tables 1, 2, 3, 4). The more differentially
expressed genes detected, the higher the rank of the nor-
malization method. The mean, median and standard
deviation of the ranks across all the time points were cal-
culated for each normalization approach and are shown
in Tables 1, 2, 3, 4 and Figure 4. For all the statistical tests
performed, CyclicLoess has the highest mean and median
ranks among all the normalization methods; the mean
and median ranks of Qspline are also consistently higher
than those of Median; Quantile fails to outperform
Median in Wilcoxon rank sum tests (without permuta-
Comparison of variability of the normalized data in the three sets of technical replicates from the time course dataset Figure 2
Comparison of variability of the normalized data in the three sets of technical replicates from the time course 
dataset. The density plots show the CVs of all data points (either non-normalized or normalized with the five normalization 
methods) from each set of the technical replicates (TRC1, TRC2 and TRC3).
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Table 1: Ranks of the normalization methods in Welch's t-tests (without permutation) in the time course dataset. For each time point, 
the normalization strategies were ranked based on the numbers of differentially expressed genes estimated from the normalized data 
using Welch's t-tests without permutation. The more differentially expressed genes detected, the higher the rank of the normalization 
method. The mean, median and standard deviation of the ranks across all the time points were calculated for each method and are 
shown in the "Mean Rank", "Median Rank" and "Standard Deviation" columns, respectively. For each column in the table, the highest 
mean, median and standard deviation of the ranks are shown in bold.
Normalization 
Method
Rank Mean Rank Median Rank Standard 
Deviation
1d 3d 7d 14d 30d
N o n o r m 21111 1 . 210 . 4
M e d i a n 12325 2 . 621 . 5
CyclicLoess 5 3 5 66 5 . 0 51.2
Quantile 3 5 6 334 . 031 . 4
Iset 662 5 2 4.2 5 2.0
Q s p l i n e 44444 4 . 04 0BMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
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tion); Iset fails to improve over Median in Wilcoxon rank
sum tests (both with and without permutation).
Notably, compared to the other normalization methods,
Iset has the highest standard deviations of the ranks across
all time points in almost all the statistical tests (3 out of
the 4 tests) (Tables 1, 2, 3 and Figure 4). For example, the
ranks of Iset range from 2 (in 7-day and 30-day treat-
ments) to 6 (in 1-day and 3-day treatments) in Welch's t-
tests without permutation (Table 1). It has been shown
previously that the performance of Iset is dependent on
the choice of the baseline array [17]; our results here sug-
gest that even with a fixed choice of the baseline array, its
performance may also depend on the arrays to be normal-
ized.
In addition to the comparisons between the control group
and each test group, we used the Analysis of Variance
(ANOVA) to estimate the number of differentially
expressed genes whose intensity values varied with the
days of the treatment. CyclicLoess reveals the largest
number of differentially expressed genes (68 genes) with
ANOVA. Iset, Qspline and Quantile reveal slightly fewer
numbers of differentially expressed genes (66, 56 and 54
Comparison of the numbers of differentially expressed genes estimated from the normalized time course dataset using multiple  statistical tests Figure 3
Comparison of the numbers of differentially expressed genes estimated from the normalized time course 
dataset using multiple statistical tests. The x-axis in each plot shows the days when the rats were treated. The y-axis rep-
resents the numbers of differentially expressed genes detected between the control vs. each test group using the following sta-
tistical tests: Welch's t-tests without permutation (T-test), Wilcoxon rank sum tests without permutation (Wilcoxon test), 
Welch's t-tests with permutation (T-test, perm), and Wilcoxon rank sum tests with permutation (Wilcoxon test, perm).
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genes, respectively), but they still significantly outperform
Median and Nonorm (which reveal only 24 and 9 differ-
entially expressed genes, respectively).
The comparison of the normalization methods in the
time course dataset can be summarized as follows. For
noise removal and signal retention, CyclicLoess demon-
strates the greatest and most consistent improvement over
Median; Qspline exhibits consistent yet moderate
improvement over Median. Quantile performs consist-
ently better than Median for variability reduction, yet does
not do so for signal detection. Iset fails to improve over
Median consistently for either noise reduction or signal
retention.
Since CyclicLoess, Quantile and Qspline exhibit consider-
able improvement over Median in the time course dataset,
we compared them in greater detail using another dataset,
the IPF dataset (see Methods), which contains larger and
more balanced numbers of arrays for both the control
(control patients) and test groups (pulmonary fibrotic
patients). To focus the comparison on these methods, we
excluded Nonorm and Iset from further analyses.
Variability of the normalized IPF dataset
Since there were no technical replicates in the IPF dataset,
we compared the four normalization methods (Cycli-
cLoess, Quantile, Qspline, and Median) for noise removal
using the positive control probes on the CodeLink Bioar-
rays. The CV of the normalized intensity values across all
arrays was calculated for each positive control probe in the
IPF dataset processed with the normalization methods.
Our results show that CyclicLoess, Quantile and Qspline
all have significantly lower mean CVs (79%, 76% and
74%, respectively) than Median (89%). CyclicLoess has a
slightly higher, yet not statistically significant mean CV
than Quantile and Qspline (Welch's t-tests,  p-values >
0.05).
Signal in the normalized IPF dataset
Table 5 and Figure 5 show the numbers of differentially
expressed genes estimated from the normalized IPF data-
set using Welch's t-tests and Wilcoxon rank sum tests, with
Table 2: Ranks of the normalization methods in Wilcoxon tests (without permutation) in the time course dataset. For each time point, 
the normalization strategies were ranked based on the numbers of differentially expressed genes estimated from the normalized data 
using Wilcoxon rank sum tests without permutation. "Rank" and the "Mean", "Median" and "Standard Deviation" of the ranks are 
defined as described in Table 1. For each column in the table, the highest rank(s), the mean, median and standard deviation of the 
ranks are shown in bold.
Normalization 
Method
Rank Mean Rank Median Rank Standard 
Deviation
1d 3d 7d 14d 30d
Nonorm 3.5 1111 1 . 511 . 1
Median 3.5 6 3 2 4 3.7 3.5 1.5
CyclicLoess 3.5 55564 . 95 0.9
Quantile 3.5 3433 3 . 330 . 4
Iset 3.5 226 2 3.1 2 1.7
Qspline 3.5 4 6 4 5 4.5 4 1
Table 3: Ranks of the normalization methods in Welch's t-tests (with permutation) in the time course dataset. For each time point, 
the normalization strategies were ranked based on the numbers of differentially expressed genes estimated from the normalized data 
using Welch's t-tests with permutation. "Rank" and the "Mean", "Median" and "Standard Deviation" of the ranks are defined as 
described in Table 1. For each column in the table, the highest rank(s), the mean, median and standard deviation of the ranks are 
shown in bold.
Normalization 
Method
Rank Mean Rank Median Rank Standard 
Deviation
1d 3d 7d 14d 30d
Nonorm 3.5 1111 1 . 511 . 1
Median 3.5 2425 3 . 3 3 . 5 1 . 3
CyclicLoess 3.5 4.5 3 5 64 . 4 4 . 5 1.2
Quantile 3.5 4.5 5 3 3 3.8 3.5 0.9
Iset 3.5 6 2 6 2 3.9 3.5 2.0
Qspline 3.5 3 6 4 4 4.1 4 1.1BMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
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and without permutation. In three of the four statistical
tests (t-tests with permutation and Wilcoxon tests with
and without permutation, Figure 5), CyclicLoess reveals
the largest numbers of differentially expressed genes (164,
331 and 297 genes, respectively) (Table 5), which are sig-
nificantly greater than the numbers of differentially
expressed genes revealed by Median (108, 279 and 227
genes, respectively). In all the statistical tests, Qspline
reveals more differentially expressed genes than Quantile,
which in turn outperforms Median (Table 5).
Overall, comparative results of the four normalization
methods in the IPF dataset agree with most of those from
the time course dataset: CyclicLoess and Qspline exhibit
significant and consistent improvement over Median in
both noise reduction and signal retention; CyclicLoess
reveals slightly more signal (differentially expressed
genes) than Qspline. Quantile outperforms Median for
both noise reduction and signal retention in all four sta-
tistical tests, which is in contrast to its performance in the
time course dataset where it fails to reveal more signal
than Median in some tests (e.g., Wilcoxon rank sum tests,
without permutation).
Discussion
CodeLink Bioarrays are recently introduced, single-color
oligonucleotide microarrays, which differ from Affymetrix
GeneChips in the following aspects [22,26]: 1) CodeLink
Bioarrays use a single pre-synthesized, pre-validated 30-
mer probe to detect each target transcript, whereas Gene-
Chips use multiple in-situ  synthesized, 25-mer probes;
and 2) the surface of CodeLink Bioarrays is made of 3-
dimensional aqueous gel matrix, whereas that of Affyme-
trix GeneChips is made of 2-dimensional glass matrix.
These characteristics suggest that CodeLink Bioarrays
behave differently from GeneChips and may require dif-
ferent normalization strategies from the ones optimized
for GeneChips.
In this study, in order to determine the best normalization
method(s) for CodeLink Bioarrays, we compared five
existing approaches designed for high-density oligonucle-
otide microarrays. These methods have been applied pre-
viously to Affymetrix GeneChip data. Our goal is to
provide a guideline for practitioners in the choice of a
'proper' normalization method that removes variability
and retains signal effectively for CodeLink Bioarray data
and thus to ensure the validity of downstream data analy-
ses. Using our criteria, the Median normalization method
(recommended by the manufacturer) is insufficient for
Table 4: Ranks of the normalization methods in Wilcoxon tests (with permutation) in the time course dataset. For each time point, 
the normalization strategies were ranked based on the numbers of differentially expressed genes estimated from the normalized data 
using Wilcoxon rank sum tests with permutation. "Rank" and the "Mean", "Median" and "Standard Deviation" of the ranks are defined 
as described in Table 1. For each column in the table, the highest rank(s), the mean, median and standard deviation of the ranks are 
shown in bold.
Normalization 
Method
Rank Mean Rank Median Rank Standard 
Deviation
1d 3d 7d 14d 30d
Nonorm 3.5 1111 1 . 5 1 1 . 1
Median 3.5 6 3 2 3 3.5 3 1.5
CyclicLoess 3.5 5566 5 . 1 5 1.0
Quantile 3.5 3434 3 . 5 3 . 5 0 . 5
Iset 3.5 2252 2 . 9 2 1 . 3
Qspline 3.5 4 6 4 54 . 541 . 0
Table 5: Numbers of differentially expressed genes estimated from the IPF dataset. Columns show the normalization methods used to 
process the IPF dataset. Rows show the statistical tests performed to detect the numbers of differentially expressed genes (adjusted p-
values < 0.05) from the normalized data. For each statistical test, the largest number of differentially expressed genes is shown in 
bold.
Median CyclicLoess Quantile Qspline
Welch's t-test 220 240 242 269
Wilcoxon test 108 164 127 136
Welch's t-test (perm) 279 331 314 319
Wilcoxon test (perm) 227 297 259 271BMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
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noise removal in the two examined CodeLink Bioarray
datasets, whereas CyclicLoess and Qspline show consider-
able and consistent improvement over Median for both
variability reduction and signal retention. CyclicLoess per-
forms slightly better than Qspline for signal retention.
Quantile exhibits moderate improvement over Median
for variability reduction and signal retention in the IPF
dataset, yet it fails to do so for signal retention in the time
course dataset. Iset fails either to remove noise or to retain
signal more effectively and consistently than Median in
the time course dataset.
Ranks of the normalization methods in the normalized time course dataset Figure 4
Ranks of the normalization methods in the normalized time course dataset. The mean, median and standard devia-
tion of the ranks of the normalization method are defined in Table 1. The bar plots are visual representation of the results 
shown in Tables 1–4 (the "Mean Rank", "Median Rank" and "Standard Deviation" columns). In each plot, mean ranks are shown 
in pink, median ranks are in blue, and standard deviations of the ranks are shown as the error bars on top of the "Mean" rank 
bars.
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A major difference between CyclicLoess, Qspline, Quan-
tile, and Iset can be explained as follows. CyclicLoess and
Qspline have more relaxed assumptions on microarray
data than Quantile and Iset. The former methods require
only that genes on the arrays are randomly distributed
(i.e., the numbers of up- and down-regulated genes are
similar), whereas the latter approaches require either that
the data on different arrays have the identical distribution
(Quantile) or that few genes on the arrays are differen-
tially expressed (Iset). Since we expected neither identical
nor very different gene expression patterns between the
control vs. test groups in the examined datasets, Cycli-
cLoess and Qspline seem to be more reasonable choices
for normalizing these data. This may account for their bet-
ter performances in this work. Our results also partially
agree with another comparative study using Affymetrix
GeneChip data [27], which showed that CyclicLoess
reduced variability and retained signal more effectively
Comparison of the numbers of differentially expressed genes estimated from the normalized IPF dataset using multiple statisti- cal tests Figure 5
Comparison of the numbers of differentially expressed genes estimated from the normalized IPF dataset using 
multiple statistical tests. The x-axis shows the numbers of differentially expressed genes estimated using the following sta-
tistical tests: Welch's t-tests without permutation (T-test), Wilcoxon rank sum tests without permutation (Wilcoxon test), 
Welch's t-tests with permutation (T-test, perm), and Wilcoxon rank sum tests with permutation (Wilcoxon test, perm). The y-
axis represents the p-values adjusted using the Benjamini & Hochberg FDR procedure. The red line shows the cut off adjusted 
p-value of 0.05.
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than Quantile. This suggests that CyclicLoess (and
Qspline) may be more suitable than Quantile (and Iset)
for normalizing single-color, oligonucleotide microarray
data.
Besides the difference mentioned above, two baseline-
array approaches, Qspline and Iset, also differ in the fol-
lowing way. Although both methods use a subset of genes
to estimate intensity-dependent differences between a
pair of microarrays for normalization, Qspline chooses
these genes evenly over the entire range of the genes on
the arrays. Iset, however, uses rank invariant genes, which
are usually in small numbers (about 300 – 1000 genes in
the examined datasets) and thus may be insufficient for
estimating intensity effect accurately in some arrays. This
may account for the unstable performance of Iset in the
time course dataset. Moreover, although intuitively nor-
malization should be more effective if a 'proper' set of
'housekeeping' genes can be selected, the effectiveness of
such approach could be limited by the still unanswered
question as to whether these genes exists in higher organ-
isms [28].
Since Qspline is a baseline-array approach, a concern
could be raised that its performance may depend on the
choice of the baseline array. Indeed, it has been shown
that the performance of Iset varied when different individ-
ual arrays were used as the baseline array [17]. However,
when the 'synthetic' baseline array was employed such
that the intensity value of each gene in this array is equal
to the median or mean of the intensity values of the same
gene across all arrays, the performance of Iset seemed to
be stable compared to Nonorm and Quantile Normaliza-
tion [17]. This suggests that these 'synthetic' baseline
arrays (the ones we used in this study for Iset and Qspline)
are less biased and therefore are better choices for base-
line-array approaches.
In addition to the examined normalization methods,
there are other approaches that can be applied to Code-
Link Bioarray data. For example, mean cyclic loess [29]
and fast linear loess [27] were designed as speed-up ver-
sions of CyclicLoess (which, as has been often noted, has
the drawback of being computationally slow). Although
proposed independently, mean cyclic loess and fast linear
loess are virtually identical methods. Unlike CyclicLoess,
which adjusts intensity-dependent differences between
each pair of arrays by iterating over all pairs of arrays in
the dataset (see Methods), the speed-up methods elimi-
nate the iteration step. Instead, for each target array, they
first make a reference array by having the intensity value
of each gene equal to the mean intensity value of the same
gene across the rest of the arrays, and then estimate and
adjust intensity-dependent differences in the target array
with respect to the reference array. These methods are sim-
ilar to Qspline when the latter chooses a similar baseline
array (i.e., using the array-wise mean intensity value for
each gene to construct the baseline array, the one we used
in this study).
There are two possible limitations in this study. The first
is that in the time course dataset, the sample sizes of the
control vs. test groups were not well balanced (i.e., the
control group contained 14 arrays, while the test groups
contained only 4 – 6 arrays each). Since a single statistical
test could be biased or less powerful for estimating differ-
entially expressed genes in unbalanced datasets, we used
multiple statistical tests (parametric and non-parametric
in nature, with and without permutation) to assess the
performances of the normalization strategies. The conclu-
sion of the comparative performances of the normaliza-
tion methods was made based on the results from all the
statistical tests. Moreover, we confirmed the evaluation
results from the time course dataset using the IPF dataset.
The latter dataset was better balanced in terms of the sam-
ple sizes of the control vs. test groups (11 and 15 arrays,
respectively), and therefore allowed more accurate estima-
tion of the numbers of the differentially expressed genes
in the normalized data.
The second possible limitation of this study is that, since
no spike-in datasets were available for CodeLink Bioar-
rays, two real CodeLink Bioarray datasets were used
instead. It would be more informative if a fixed number of
known differentially expressed genes were present in the
data. However, this information is often unknown for real
microarray datasets. Although spike-in or dilution data
has been shown to be useful for evaluation of normaliza-
tion methods [17,30], they are too clean in terms of the
'background' genes, whose intensity values are constant
between control vs. test groups. In real data, these 'back-
ground' genes rarely exist. In fact, in the two examined
datasets, we neither knew the number of 'background'
genes in the control vs. test groups, nor did we even know
the number of these genes within each group (since indi-
vidual samples of each group were different). For this rea-
son, normalization strategies that perform well in spike-in
or dilution data may not perform equally well in real data.
It may be the most informative if normalization methods
can be evaluated using both real and spike-in microarray
data.
Methods
Datasets
Two real datasets were used in this study.
Time course dataset
These data were collected to test the difference between a
control group of rats (exposed to a treatment for 0 days)
and test groups of rats exposed to a treatment for either 1,BMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
Page 11 of 14
(page number not for citation purposes)
3, 7, 14 or 30 days. The control group contained 14 arrays.
The 14-day treatment group contained 6 arrays, and the
other test groups contained 4 arrays each. Thus, the data-
set contained 36 arrays. For the control group, there were
3 sets of technical replicates, sets TRC1, TRC2 and TRC3,
which contained 5, 5 and 4 arrays, respectively. The arrays
used in this dataset were CodeLink UniSet Rat I Bioarrays
containing pre-validated oligonucleotide probes targeting
about 10K transcripts in the rat genome.
IPF dataset
This dataset was generated to compare expression profiles
of control lungs vs. lungs from patients with idiopathic
pulmonary fibrosis (IPF). A total of 26 microarrays were
obtained from 11 controls and 15 patients. The arrays
used were CodeLink UniSet Human I Bioarrays contain-
ing pre-validated oligonucleotide probes targeting about
10K transcripts in the human genome. The arrays are
available at the Gene Expression Omnibus (GEO acces-
sion number GSE 2052).
Both of the above CodeLink Bioarray platforms contain
68 bacterial control probes on each array, of which 18 are
positive control probes (which can be used to monitor the
quality of microarray experiments, see below) and 50 are
negative control probes (which can be used to determine
the low limit of signal). Each control probe is spotted 6
times on each array.
Microarray protocol
A CodeLink Bioarray experiment involves the following
steps. Total RNAs are first prepared from a biological sam-
ple. Then a set of bacterial mRNAs of known concentra-
tions (which are provided by the manufacturers and have
complementary sequences to the positive control probes
on the Bioarrays) are spiked in as positive controls. The
mixed mRNAs are reverse transcribed into cDNAs and
amplified into cRNAs, using in vitro transcription. The
cRNAs are labeled with a fluorescent dye and hybridized
to a CodeLink Bioarray presynthesized with probes.
Finally the array is washed and scanned. The intensity
value (signal) of the fluorescent dye detected from each
probe on the array is proportional to the abundance of the
targeting transcript in the sample of interest. The quality
of these processes can be monitored by detecting the sig-
nal of the positive control probes on the Bioarrays.
Since some normalization methods (e.g., Quantile and
Qspline) do not perform well with missing values in
microarray data, missing values in the raw data were
imputed before normalization using the following proce-
dure. For each dataset, we first removed genes which con-
tained missing values in more than 5% of the microarrays,
then used the k-NNimpute algorithm [31] to fill in miss-
ing values for the remaining genes. The k-NNimpute algo-
rithm was implemented using the Bioconductor package/
function pamr/pamr.knnimpute(k = 10) [32].
Normalization methods
All of the examined normalization methods are available
at http://www.bioconductor.org[33].
Global approaches
We compared three global normalization methods,
Median, CyclicLoess and Quantile. For reference, we also
included Nonorm, which does not perform any data
transformation on raw intensity values, S, of the spots on
an array, which is defined as S = Sf - Sb, where Sf is the flu-
orescent signal of the spots and Sb is the local background
intensity values of the spots. Median normalization scales
the raw intensity values on an array using the median of
the raw intensity value, i.e., Sn = S/median(S), where Sn is
the normalized intensity values of the spots. Median is
recommended by the manufacturer for normalization
and serves as a baseline method in this study (Note: this
should not be confused with the 'baseline-array'
approaches described below). The Median-normalized
CodeLink Bioarray data was obtained directly from the
software provided by the manufacturer.
CyclicLoess [17] adjusts intensity-dependent differences
between pairs of arrays with the aid of the MA plot
(which, when used on data obtained from single-color
microarrays, is the scatter plot of average log intensity val-
ues [A] of a pair of arrays vs. log intensity ratio [M] of the
same arrays) [17]. CyclicLoess is an inter-microarray vari-
ant of loess-based normalization methods originally
applied to two-color cDNA microarrays to adjust the
intensity-dependent dye effect within a microarray
[19,24]. In two-color cDNA microarrays, a test- and a ref-
erence sample (labeled with two fluorescent dyes of dis-
tinct colors, i.e., red and green, respectively) are
hybridized to the same array; the differences of gene
expression between these samples can be obtained by
comparing the red and green fluorescent intensities of
each gene on the same array. Thus intra-microarray loess-
based normalization approaches can be used to adjust
intensity-dependent differences in each microarray. In
single-color microarrays, however, only one sample is
hybridized to each microarray, and the differences of gene
expression between different samples can only be
obtained by comparing intensity values of each gene on
different arrays. Inter-microarray normalization methods
(e.g., CyclicLoess studied here), therefore, have to be used
to estimate and minimize intensity-dependent differences
in these microarrays.
CyclicLoess uses the MA plot and loess smoothing [34] to
estimate intensity-dependent differences in a pair of
microarrays, and then removes these differences byBMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
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centering the loess line to zero. This procedure is carried
out in a pairwise manner for all the arrays in a dataset and
iterated until intensity-dependent differences are removed
from all arrays. CyclicLoess was implemented using the
Bioconductor package/function affy/normal-
ize.loess(data, epsilon = 1, log.it = F, span = 0.4, maxit
= 2) [35]. The parameter epsilon in normalize.loess
measures intensity-dependent differences in the data and
thus serves as a criterion for the procedure to stop iterat-
ing. Our results show that when epsilon is smaller than 1,
intensity-dependent differences in the data are negligible.
The smaller value of epsilon does not produce better
results in terms of variability reduction and signal reten-
tion (data not shown). It took CyclicLoess two iterations
in the time course dataset and one iteration in the IPF
dataset to satisfy the stopping criterion (epsilon < 1).
Quantile [17] normalizes data in the following way. It first
ranks data on each array, and then assigns data of the
same rank across all arrays the mean of the data (of the
same rank). Quantile normalization was implemented
using the Bioconductor package/function affy/normal-
ize.quantiles(data).
Baseline-array approaches
We compared two baseline-array methods, Iset and
Qspline. These two strategies share several similarities: 1)
both need to choose a baseline-array to estimate intensity-
dependent differences in target arrays; 2) both use a spline
smoothing technique to remove intensity-dependent dif-
ferences in target arrays; 3) both estimate smoothing
curves for normalization using a subset of the genes on
the arrays; and 4) both are rank-based methods. However,
they differ in their choices of the subset of genes for fitting
normalization curves. Iset chooses these genes by select-
ing a set of rank-invariant genes (or so called "housekeep-
ing genes") in the target array with respect to the baseline
array [36,37], while Qspline does so by first ranking all
the genes on the target array and the baseline array respec-
tively, and then by using quantiles of the ranked genes to
estimate smoothing curves [38].
Iset was implemented in the Bioconductor package/func-
tion affy/normalize.invariantset ("target", "ref", prd.td =
c(0.003, 0.007)), where "target" is the data matrix from
the target array and "ref" is the data matrix from the base-
line array. We chose the baseline array for Iset as follows:
the intensity value of each gene is the median of the inten-
sity values of the same gene across all arrays. Qspline was
implemented in the Bioconductor package/function affy/
normalize.qspline (data, fit.iters = 5, min.offset = 5,
spar = 0, p.min = 0, p.max = 1.0). We chose the baseline
array for Qspline using the default option, in which each
gene in the baseline array had the intensity value equal to
the mean of the intensity values of the same gene across
all arrays.
Detection of noise in the normalized datasets
We applied the five normalization methods individually
to the time course and IPF datasets. In order to assess the
effectiveness of the normalization methods in removing
noise, we first used three sets of technical replicate micro-
arrays, sets TRC1, TRC2 and TRC3, from the time course
dataset. For each set of the replicates, we used pairwise MA
plots to examine intensity-dependent differences in the
data that are normalized individually with the normaliza-
tion methods; we then calculated the coefficient of varia-
tion (CV) of the normalized intensity values for each
transcript (gene) across all arrays. Specifically, if we let Sk
denote the vector of normalized intensity values for tran-
script k in technical replicate set j, Sk = (sk,1,..., sk,m,...sk,M)
where m denotes the mth array in set j and 1 ≤ m ≤ M. The
CV of Sk is computed as follows:
CV (Sk) = standard deviation (Sk)/mean (Sk) × 100%.
Finally, we exploited the redundancy in the positive con-
trol probes on the arrays and measured the CVs for these
probes across all arrays in the time course dataset. Simi-
larly as above, we let Sc denote the vector of normalized
intensity values for the positive control probe c on array n,
and  Sc  = (sc,1,1,...sc,p,1,...sc,6,1,...,sc,p,n,...sc,6,N), where p
denotes the pth positive control probe c on array n, 1 ≤ p
≤ 6 (i.e., each positive control probe is spotted six times on
each array), where 1 ≤ n ≤ N and N (= 36) is the total
number of arrays in the entire time course datasets. The
CV of Sc is computed as follows:
CV (Sc) = standard deviation (Sc)/mean (Sc) × 100%.
Since the IPF dataset did not contain technical replicates,
we measured and compared the CVs for each positive con-
trol probe across all arrays in the IPF data normalized with
the normalization methods. The normalized intensity val-
ues used in this section for calculating CVs are on the scale
of the raw intensity data (i.e., not log-transformed values).
Detection of signal in the normalized datasets
A negative control threshold TNC is used (as suggested by
CodeLink Bioarrays) to monitor the low limit of signal
[39], where TNC is defined as TNC = (80% trimmed mean
of negative control probes) + (3 standard deviations of the
80% trimmed population of negative control probes). In
order to minimize the effects of low signal probes (whose
intensity values are smaller than the negative control
threshold) on signal detection, we replaced intensity val-
ues of these probes with TNC.BMC Bioinformatics 2005, 6:309 http://www.biomedcentral.com/1471-2105/6/309
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Log-transformed, normalized intensity values were used
in the analyses described below.
In order to compare the effectiveness of the normalization
methods in enhancing signal reproducibility, we detected
signal in the normalized datasets. We assume that signal
quality can be estimated by the number of differentially
expressed genes detected (that is, the more signal retained
in the normalized data, the more differentially expressed
genes should be revealed). We first developed a simula-
tion model and verified this intuition using simulated
data (see additional file1: Simulation model and data for
detail).
We then used multiple statistical significance tests, both
parametric (e.g., Welch's two-sample t-tests and ANOVA)
and non-parametric (e.g., Wilcoxon rank sum tests), to
detect differentially expressed genes in the normalized
datasets. Raw p-values of the t-statistics and Wilcoxon rank
sum tests were computed using the null distribution of
the test statistics as well as the permutation tests of the
sample labels. These p-values were then adjusted for mul-
tiple testing using the false discovery rate (FDR) control-
ling procedure of Benjamini & Hochberg [40], which
seems to balance the control of both false-positive and
false-negative error rates better than other procedures
(e.g., Bonferroni, the Benjamini & Yekutieli FDR and
SAM) [41]. The cut-off adjusted p-value of 0.05 was used
to determine differentially expressed genes for these two-
sample statistical tests.
In addition to pair-wise comparisons between the control
and test groups, we used ANOVA to detect genes whose
intensity values varied with the length of the treatment.
Since we believe that there was a non-linear relationship
between the response- (intensity values of genes) and the
explanatory variables (days of the treatment), we used a
quadratic regression model to fit these variables. For tran-
script k, where 1 ≤ k ≤ K and K is the total number of the
transcripts on the array, let j be the treatment group, 1 ≤ j
≤ 6; for array i in treatment group j and 1 ≤ i ≤ Nj, where
Nj is the number of the arrays for treatment group j, let sk,i,j
denote the intensity value of transcript k on array i in treat-
ment group j and di,j be the day of treatment for array i in
treatment group j, i.e., di,j = {0,1,3,7,14,30}. The quadratic
regression model can be written as:
ANOVA was used to estimate statistical significance of the
model parameters β1 and β2 for all transcripts, 1 ≤ k ≤ K.
The p-values of the F statistics were adjusted using the Ben-
jamini & Hochberg FDR procedure. To ensure that both β1
and β2 are non-zero and thus minimize the risk of false
positives, a stringent criterion, the adjusted p-value < 0.01,
was used to determine differentially expressed genes.
List of abbreviations
ANOVA: Analysis of Variance;
CV: coefficient of variation;
FDR: false discovery rate;
IPF: idiopathic pulmonary fibrosis;
loess: local regression estimation.
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